Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions

To analyze whether 1 of the 2 apheresis techniques, therapeutic plasma exchange (PE) or immunoadsorption (IA), is superior in treating neuromyelitis optica spectrum disorder (NMOSD) attacks and to identify predictive factors for complete remission (CR).

Bibliographic Details

Main Authors:	Kleiter, Ingo Wolfram (Author) , Wildemann, Brigitte (Author)
Format:	Article (Journal)
Language:	English
Published:	September 26, 2018
In:	Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology Year: 2019, Volume: 5, Issue: 6
ISSN:	2332-7812
DOI:	10.1212/NXI.0000000000000504
Online Access:	Resolving-System, Volltext: https://doi.org/10.1212/NXI.0000000000000504 Verlag: https://nn.neurology.org/content/5/6/e504
Author Notes:	Ingo Kleiter, Anna Gahlen, Nadja Borisow, Katrin Fischer, Klaus-Dieter Wernecke, Kerstin Hellwig, Florence Pache, Klemens Ruprecht, Joachim Havla, Tania Kümpfel, Orhan Aktas, Hans-Peter Hartung, Marius Ringelstein, Christian Geis, Christoph Kleinschnitz, Achim Berthele, Bernhard Hemmer, Klemens Angstwurm, Jan-Patrick Stellmann, Simon Schuster, Martin Stangel, Florian Lauda, Hayrettin Tumani, Christoph Mayer, Markus Krumbholz, Lena Zeltner, Ulf Ziemann, Ralf Linker, Matthias Schwab, Martin Marziniak, Florian Then Bergh, Ulrich Hofstadt-van Oy, Oliver Neuhaus, Uwe K. Zettl, Jürgen Faiss, Brigitte Wildemann, Friedemann Paul, Sven Jarius, and Corinna Trebst, on behalf of NEMOS (Neuromyelitis Optica Study Group)